Soft Tissue Repair 2017 Global Market Expected to Grow at CAGR of 13.32% and Forecast to 2021

Wiseguyreports.Com Publish New Market Research Report On-“Soft Tissue Repair 2017 Global Market Expected to Grow at CAGR Of 13.32% and Forecast to 2021”.


New York, NY -- (SBWIRE) -- 09/26/2017 -- Soft Tissue Repair Market 2017

Executive Summary
Soft tissue repair market consists of cell therapy-based products, tissue scaffolds, and soft tissue fixation devices and accessories. Cell therapy and tissue scaffold products are developed through bioengineering, which requires extensive funding to conduct R&D and clinical trials. Hence, support from the governments in developed countries will encourage various large and small companies to develop novel technology.

The analysts forecast the global soft tissue repair market to grow at a CAGR of 13.32% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global soft tissue repair market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1120151-global-soft-tissue-repair-market-2017-2021

The report, Global Soft Tissue Repair Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Acelity
- Arthrex
- Ethicon
- Medtronic

Other prominent vendors
- ACE Surgical Supply
- AlloCure
- AlloSource
- Anterogen
- Antibe Therapeutics
- Athersys
- Avita Medical
- AxoGen
- Bacterin International
- Baxter
- Biogen
- BioRestorative Therapies
- Biostage
- BioTissue Technologies
- BrainStorm Cell Therapeutics
- Caladrius Biosciences
- Celgene
- Cell Therapy
- CRC for Cell Therapy Manufacturing
- Fibrocell Science
- Healthpoint
- Histogen
- Holostem Terapie Avanzate
- Integra Life Sciences
- ISTO Technologies
- Janssen Pharmaceutical
- K2M
- Mesoblast
- NeoStem
- Neuralstem
- Orteq
- Osiris Therapeutics
- Osteotech
- Orthofix International
- Parcus Medical
- Regenerys
- SanBio
- Soft Tissue Regeneration

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/1120151-global-soft-tissue-repair-market-2017-2021

Table of Contents – Key Points Analysis

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
- Key market highlights
- Government funding and support encouraging soft tissue repair market
- Focus to expand market presence by vendors

PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis

PART 06: Market segmentation by product
- Global cell therapy market
- Global tissue scaffold market
- Global soft tissue fixation devices and accessories

PART 07: Market segmentation by application
- Neurology and orthopedic
- Dermatology
- Dental
- Breast cancer

PART 08: Market segmentation by end-users
- Hospitals and clinics
- ASCs
- Physicians' offices

PART 09: Geographical segmentation
- Soft tissue repair market in Americas
- Soft tissue repair market in EMEA
- Soft tissue repair market in APAC

PART 10: Market drivers
- Rising incidence of accidental injuries
- Rise in strategic partnerships for distribution of products
- Reimbursement for soft tissue repair products

PART 11: Impact of drivers
PART 12: Market challenges
- High cost of clinical trials and failure rate in clinical trials
- Complications associated with soft tissue repair products
- Stringent regulatory impeding product approvals
- Critical ethical challenges with respect to stem cell research

PART 13: Impact of drivers and challenges
PART 14: Market trends
- Gene therapy – An emerging trend in the market
- Increasing strategic alliances
- Development of novel products

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1120151